Proteome Sciences has established a comprehensive intellectual property portfolio covering markers in CNS disorders (Alzheimer’s, stroke, traumatic brain injury, TSE’s & pain), Cancer (lung, breast, esophageal, colorectal cancers & neuroblastoma) and organ transplant rejection(renal, cardiac).
All biomarker portfolios are available for licensing to companies wishing to develop targeted assays for research and/or clinical use. 

A list of selected applications from tissue and body fluids available upon request.

There was a problem with your submission. Please correct the issues below

    Here at PROTEOME SCIENCES we take your privacy seriously and will only use your personal information to administer your account and to provide the products and services you have requested from us.

    However, from time to time we would like to contact you with details of new or improved services. If you consent to us contacting you for this purpose please tick to say how you would like us to contact you:

    Proteome Sciences

    Corporate and Registered Office

    Proteome Sciences plc
    5 Dashwood Lang Road
    Bourne Business Park
    KT15 2HJ
    United Kingdom

    Tel: +44 (0)20 7043 2116
    Fax: +44 (0)20 3637 7516